CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionOperating margin is -248.5%, lower than 95% of its Medical Devices peers (median 7.3%)
- FinancialsLow earnings quality
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
528.74MUSDvs all stocks (USD)
Revenue (TTM)
48.55MUSDvs all stocks (USD)
Profit Margin
-225.34%vs Medical Devices peers
Beta
1.08xvs all stocks
52-Week Change
12.19%vs all stocks
Market Capitalization
528.74MUSDvs all stocks (USD)
Enterprise Value
448.90MUSDvs all stocks (USD)
Forward P/E
-5.14xvs Medical Devices peers
Price to Sales (TTM)
10.89xvs Medical Devices peers
Price to Book (MRQ)
5.85xvs Medical Devices peers
Enterprise to Revenue
9.25xvs Medical Devices peers
Enterprise to EBITDA
-4.21xvs Medical Devices peers
Gross Margin
59.10%vs Medical Devices peers
Profit Margin
-225.34%vs Medical Devices peers
Operating Margin
-248.48%vs Medical Devices peers
Return on Assets (TTM)
-41.41%vs Medical Devices peers
Return on Equity (TTM)
-118.24%vs Medical Devices peers
Revenue (TTM)
48.55MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.00USDUpdated Sep 28, 2026Quarterly Revenue Growth
117.80%vs Medical Devices peers
Gross Profit (TTM)
26.64MUSDvs all stocks (USD)
EBITDA (TTM)
-106.51MUSDvs all stocks (USD)
Net Income (TTM)
-109.39MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-95.94MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-59.24MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
35.26MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
19.49MUSDFY2025 · Dec 31, 2025Gross Profit
15.76MUSDFY2025 · Dec 31, 2025Operating Income
-68.34MUSDvs all stocks (USD)
Pre-tax Income
-69.11MUSDFY2025 · Dec 31, 2025Net Income
-69.11MUSDFY2025 · Dec 31, 2025EBIT
-64.16MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-62.65MUSDFY2025 · Dec 31, 2025Research & Development
31.59MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
52.51MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.20MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.95MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-69.11MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-64.58MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
40.55MUSDFY2025 · Dec 31, 2025Interest Paid
4.05MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-69.11MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.51MUSDFY2025 · Dec 31, 2025Stock-based Compensation
10.15MUSDFY2025 · Dec 31, 2025Other Non-cash Items
2.32MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.76MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.22MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.91MUSDFY2025 · Dec 31, 2025Purchase of Investments
-100.69MUSDFY2025 · Dec 31, 2025Sale of Investments
48.39MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-52.31MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-20.40MUSDFY2025 · Dec 31, 2025Other Financing Charges
-2.15MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
78.05MUSDFY2025 · Dec 31, 2025Shares Outstanding
52.86MSharesUpdated Sep 28, 2026Float Shares
43.60MSharesUpdated Sep 28, 2026Shares Short
5.05MSharesUpdated Sep 28, 2026Short Ratio
7.79daysvs all stocks
Short % of Shares Outstanding
9.81%vs all stocks
% Held by Insiders
9.86%vs all stocks
% Held by Institutions
39.64%vs all stocks
Total Cash (MRQ)
142.66MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.70USDUpdated Sep 28, 2026Total Debt (MRQ)
62.82MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6956xvs Medical Devices peers
Current Ratio (MRQ)
6.75xvs Medical Devices peers
Book Value per Share (MRQ)
1.71USDUpdated Sep 28, 2026Total Assets
126.27MUSDvs all stocks (USD)
Total Current Assets
117.53MUSDFY2025 · Dec 31, 2025Total Liabilities
65.22MUSDFY2025 · Dec 31, 2025Total Non-current Assets
8.74MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
40.88MUSDFY2025 · Dec 31, 2025Total Current Liabilities
24.35MUSDFY2025 · Dec 31, 2025Cash
6.61MUSDFY2025 · Dec 31, 2025Cash Equivalents
33.62MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
40.23MUSDFY2025 · Dec 31, 2025Other Short-term Investments
53.80MUSDFY2025 · Dec 31, 2025Accounts Receivable
12.12MUSDFY2025 · Dec 31, 2025Inventory
6.70MUSDFY2025 · Dec 31, 2025Accounts Payable
4.06MUSDFY2025 · Dec 31, 2025Short-term Debt
496.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
532.00KUSDFY2025 · Dec 31, 2025Long-term Debt
40.88MUSDFY2025 · Dec 31, 2025Common Stock (Book)
41.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.02BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
61.05MUSDvs all stocks (USD)
52-Week Low
4.79USDUpdated Sep 28, 202652-Week High
11.58USDUpdated Sep 28, 202652-Week Change
12.19%vs all stocks
Beta
1.08xvs all stocks
50-Day MA
7.85USDUpdated Sep 28, 2026200-Day MA
6.90USDUpdated Sep 28, 2026Avg 10-Day Volume
837.75KSharesUpdated Sep 28, 2026Avg 30-Day Volume
714.69KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-2.24USDUpdated Sep 28, 2026Other Income / Expense
-23.00KUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -248.5%, lower than 95% of its Medical Devices peers (median 7.3%)Significant
Operating margin: -2.48Industry median: 0.07Industry P5: -0.73Peers compared: 102
Profit margin is -225.3%, lower than 95% of its Medical Devices peers (median 4.1%)Significant
Profit margin: -2.25Industry median: 0.04Industry P5: -1.45Peers compared: 102
Return on equity is -118.2%, lower than 95% of its Medical Devices peers (median 2.5%)Significant
Return on equity: -1.18Industry median: 0.03Industry P5: -0.59Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.59Profit Margin: -2.25
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.67
High structural barrier to entryNotable
Barrier to Entry: 9.97
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
LivsMed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Eupraxia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cerus Corporation
Tier 1ProductionApproval-Gated PipelineRule
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Lifestrong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Easydiagnosis Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pulike Biological Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kingchem Liaoning Life Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eiken Chemical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule